ABSTRACT
Nosocomial infections are an important cause of morbi-mortality worldwide. The increase in the rate of resistance to conventional drugs in these microorganisms has stimulated the search for new therapeutic options. The nitro moiety (NO2) is an important pharmacophore of molecules with high anti-infective activity. We aimed to synthesize new nitro-derivates and to evaluate their antibacterial and anti-Candida potential in vitro. Five compounds [3-nitro-2-phenylchroman-4-ol (3); 3-nitro-2-phenyl-2H-chromene (4a); 3-nitro-2-(4-chlorophenyl)-2H-chromene (4b); 3-nitro-2-(4-fluorophenyl)-2H-chromene (4c), and 3-Nitro-2-(2,3-dichlorophenyl)-2H-chromene (4d)] were efficiently synthesized by Michael-aldol reaction of 2-hydroxybenzaldehyde with nitrostyrene, resulting in one ß-nitro-alcohol (3) and four nitro-olefins (4a-4d). The antibacterial and anti-Candida potentials were evaluated by assaying minimal inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and minimum bactericidal concentration (MBC). Mono-halogenated nitro-compounds (4b and 4c) showed anti-staphylococcal activity with MIC values of 15.6-62.5 µg/mL and MBC of 62.5 µg/mL. However, the activity against Gram-negative strains was showed to be considerably lower and our data suggests that this effect was associated with the outer membrane. Furthermore, nitro-compounds 4c and 4d presented activity against Candida spp. with MIC values ranging from 7.8-31.25 µg/mL and MFC of 15.6-500 µg/mL. In addition, these compounds were able to induce damage in fungal cells increasing the release of intracellular material, which was associated with actions on the cell wall independent of quantitative changes in chitin and ß-glucan. Together, these findings show that nitro-compounds can be exploited as anti-staphylococcal and anti-Candida prototypes.
Subject(s)
Anti-Infective Agents/pharmacology , Nitro Compounds/pharmacology , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Bacteria/drug effects , Bacteria/growth & development , Candida/drug effects , Candida/growth & development , Cross Infection/drug therapy , Cross Infection/microbiology , Drug Design , Humans , Microbial Sensitivity Tests , Nitro Compounds/chemical synthesis , Nitro Compounds/chemistryABSTRACT
BACKGROUND: Considering the need for the development of new antitumor drugs, associated with the great antitumor potential of thiophene and thiosemicarbazonic derivatives, in this work we promote molecular hybridization approach to synthesize new compounds with increased anticancer activity. OBJECTIVE: Investigate the antitumor activity and their likely mechanisms of action of a series of N-substituted 2-(5-nitro-thiophene)-thiosemicarbazone derivatives. METHODS: Methods were performed in vitro (cytotoxicity, cell cycle progression, morphological analysis, mitochondrial membrane potential evaluation and topoisomerase assay), spectroscopic (DNA interaction studies), and in silico studies (docking and molecular modelling). RESULTS: Most of the compounds presented significant inhibitory activity; the NCIH-292 cell line was the most resistant, and the HL-60 cell line was the most sensitive. The most promising compound was LNN-05 with IC50 values ranging from 0.5 to 1.9 µg.mL-1. The in vitro studies revealed that LNN-05 was able to depolarize (dose-dependently) the mitochondrial membrane, induceG1 phase cell cycle arrest noticeably, promote morphological cell changes associated with apoptosis in chronic human myelocytic leukaemia (K-562) cells, and presented no topoisomerase II inhibition. Spectroscopic UV-vis and molecular fluorescence studies showed that LNN compounds interact with ctDNA forming supramolecular complexes. Intercalation between nitrogenous bases was revealed through KI quenching and competitive ethidium bromide assays. Docking and Molecular Dynamics suggested that 5-nitro-thiophene-thiosemicarbazone compounds interact against the larger DNA groove, and corroborating the spectroscopic results, may assume an intercalating interaction mode. CONCLUSION: Our findings highlight 5-nitro-thiophene-thiosemicarbazone derivatives, especially LNN-05, as a promising new class of compounds for further studies to provide new anticancer therapies.
Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , DNA, Neoplasm/drug effects , Nitro Compounds/pharmacology , Thiophenes/pharmacology , Thiosemicarbazones/pharmacology , Topoisomerase II Inhibitors/pharmacology , Adult , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Cycle/drug effects , Cell Proliferation/drug effects , DNA Topoisomerases, Type II/metabolism , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Nitro Compounds/chemical synthesis , Nitro Compounds/chemistry , Structure-Activity Relationship , Thiophenes/chemical synthesis , Thiophenes/chemistry , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/chemistry , Topoisomerase II Inhibitors/chemical synthesis , Topoisomerase II Inhibitors/chemistry , Tumor Cells, CulturedABSTRACT
The guanine base in DNA, due to its low oxidation potential, is particularly sensitive to chemical modifications. A large number of guanine lesions have been characterized and studied in some detail due to their relationship with tissue inflammations. Nevertheless, one example of these lesions is the formation of 8-nitro-guanosine, but the NMR data of this compound was only partially interpreted. A comprehensive study of the two possible tautomeric forms, through a detailed characterization of this compound, has implications for its base pairing properties. The target compound was obtained through a synthetic sequence of five steps, where all intermediates were fully characterized using spectral data. The analysis of the two tautomers was then evaluated through NMR spectroscopy and theoretical calculations of the chemical shifts and NH coupling constants, which were also compared with the data from guanosine.
Subject(s)
Guanosine/analogs & derivatives , Magnetic Resonance Spectroscopy , Models, Theoretical , Nitro Compounds/chemistry , DNA/chemistry , Guanosine/chemical synthesis , Guanosine/chemistry , Hydrolysis , Magnetic Resonance Spectroscopy/methods , Mass Spectrometry/methods , Nitro Compounds/chemical synthesisABSTRACT
A series of nitroaromatic compounds was synthesized and evaluated as potential antileishmanial and trypanocidal agents. Five compounds exerted significant anti-leishmanial activity in vitro against promastigotes forms of Leishmania (L.) amazonensis, with IC(50) in the range of 23-59 µmol L(-1), but none were active against amastigotes intracellular forms of Trypanosoma cruzi. In vitro cytotoxicity on the proliferation of human peripheral blood mononuclear cells (PBMC) stimulated with phytohemaglutinin (PHA) was also evaluated. Two compounds, 6 and 7, were found to present a promising anti-leishmanial activity with IC(50) values of 59.5 and 50.6 µM, respectively, without affecting the lymphocyte proliferation in PBMCs (selectivity index of 16.1 and 21.7, respectively), indicating low toxicity to human cells.
Subject(s)
Antiparasitic Agents/chemical synthesis , Antiparasitic Agents/pharmacology , Chemistry Techniques, Synthetic , Nitro Compounds/chemical synthesis , Nitro Compounds/pharmacology , Antiparasitic Agents/chemistry , Antiparasitic Agents/toxicity , Cell Survival/drug effects , Humans , Inhibitory Concentration 50 , Leishmania/drug effects , Lymphocytes/cytology , Lymphocytes/drug effects , Nitro Compounds/chemistry , Nitro Compounds/toxicity , Trypanosoma cruzi/drug effectsABSTRACT
The vascular effects of nitrolinoleate (LNO2), an endogenous product of linoleic acid (LA) nitration by nitric oxide-derived species and a potential nitrosating agent, were investigated on rat endothelial-leukocyte interactions. Confocal microscopy analysis demonstrated that LNO2 was capable to deliver free radical nitric oxide (*NO) into cells, 5 min after its administration to cultured cells, with a peak of liberation at 30 min. THP-1 monocytes incubated with LNO2 for 5 min presented nitrosation of CD40, leading to its inactivation. Other anti-inflammatory actions of LNO2 were observed in vivo by intravital microscopy assays. LNO2 decreased the number of adhered leukocytes in postcapillary venules of the mesentery network. In addition to this, LNO2 reduced mRNA and protein expression of beta2-integrin in circulating leukocytes, as well as VCAM-1 in endothelial cells isolated from postcapillary venules, confirming its antiadhesive effects on both cell types. Moreover, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, a nitric oxide scavenger, partially abolished the inhibitory action of LNO2 on leukocyte-endothelium interaction, suggesting that the antiadhesion effects of LNO2 involve a dual role in leukocyte adhesion, acting as a nitric oxide donor as well as through nitric oxide-independent mechanisms. In conclusion, LNO2 inhibited adhesion molecules expression and promoted *NO inactivation of the CD40-CD40L system, both important processes of the inflammatory response.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , CD40 Antigens/metabolism , CD40 Ligand/metabolism , Cell Adhesion Molecules/metabolism , Linoleic Acids/pharmacology , Nitro Compounds/pharmacology , Signal Transduction/drug effects , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Cell Adhesion/drug effects , Cell Adhesion Molecules/genetics , Cell Line, Tumor , Endothelial Cells/metabolism , Gene Expression Regulation/drug effects , Humans , Leukocytes/drug effects , Leukocytes/metabolism , Linoleic Acids/chemical synthesis , Male , Microscopy, Video/methods , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Nitro Compounds/chemical synthesis , Nitrosation , RNA, Messenger/metabolism , Rats , Rats, Wistar , Venules/metabolismABSTRACT
Chagas' disease is the major endemic disease in South and Central America caused by a trypanosomatid parasite (Trypanosoma cruzi). The current treatment relies on two old and non-specific chemotherapeutic agents, Nifurtimox and Benznidazole. Despite the major advances that have been made in the identification of specific targets that afford selectivity, the drugs used today have serious side effects. Furthermore, differences in drug susceptibility among different T. cruzi isolates have led to varied parasitological cure rates depending on the geographical region. There is, therefore, an urgent need for the development of new antichagasic drugs. In this regard we have spent more than a decade in the search for more effective agents able to compromise the proliferation of T. cruzi. We began our research with our own compounds and then continued with compounds from other researcher groups. We systematically characterized representatives of a wide range of different chemical families. In this review we summarize our ongoing efforts to identify potential anti-T. cruzi agents using our compound-library. It is discussed and presented the structure-activity relationship observed among the different groups of chemical families.
Subject(s)
Chagas Disease/drug therapy , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Animals , Chagas Disease/parasitology , Heterocyclic Compounds/chemical synthesis , Heterocyclic Compounds/pharmacology , Humans , Nitro Compounds/chemical synthesis , Nitro Compounds/pharmacology , Organometallic Compounds/chemical synthesis , Organometallic Compounds/pharmacology , Trypanocidal Agents/therapeutic useABSTRACT
Nitroalkenes derivatives of free as well as esterified unsaturated fatty acids are present in human plasma and tissue, representing novel pluripotent cell signaling mediators. Lipid nitration occurs in response to pro-inflammatory stimuli as an adaptative mechanism to downregulate inflammatory responses. This chapter first discusses the generation of nitroalkenes during macrophage activation following chemical and biological characterization. In particular, it describes procedures for (a) synthesizing and characterizing esterified (cholesteryl-nitrolinoleate, CLNO2) as well as free (nitroarachidonate, AANO2) nitroalkenes, (b) determining nitration of cholesteryl linoleic acid during macrophage activation by inflammatory stimuli, (c) examining the modulatory effects of nitroalkenes on the expression of inducible enzymes by activated macrophages, and (d) discussing the signaling pathways involved in nitroalkene-mediated anti-inflammatory actions.
Subject(s)
Alkenes/chemical synthesis , Macrophage Activation/drug effects , Macrophages/drug effects , Nitro Compounds/chemical synthesis , Alkenes/chemistry , Alkenes/pharmacology , Animals , Cell Line , Humans , Mice , Nitro Compounds/chemistry , Nitro Compounds/pharmacologyABSTRACT
Nitrated fatty acids (nitroalkenes) have been recently detected and quantified in cell membranes and human plasma. However, nitration of arachidonate (AA), that could redirect AA-dependent cell signaling pathways, has not been studied in detail. Herein, we synthesized and determined for the first time the isomer distribution of nitroarachidonate (AANO2) and demonstrate its ability to modulate inflammation. Synthesis of AANO2 was achieved by AA treatment with sodium nitrite in acidic conditions following HPLC separation. Mass spectrometry (MS) analysis showed the characteristic MS/MS transition of AANO2 (m/z 348/301). Moreover, the IR signal at 1378.3 cm(-1) and NMR studies confirmed the presence of mononitrated nitroalkenes. Positional isomer distribution was determined by NMR and MS fragmentation with lithium; four major isomers (9-, 12-, 14-, and 15-AANO2) were identified, which exhibited key anti-inflammatory properties. These include their ability to release biologically relevant amounts of nitric oxide, induce cGMP-dependent vasorelaxation, and down-regulate inducible nitric oxide synthase (NOS2) expression during macrophage activation, providing unique structural evidence and novel regulatory signaling properties of AANO2.
Subject(s)
Arachidonic Acid/chemical synthesis , Arachidonic Acid/pharmacology , Nitro Compounds/chemical synthesis , Nitro Compounds/pharmacology , Animals , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Arachidonic Acid/chemistry , Cell Line , Chromatography, High Pressure Liquid , Isomerism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Mice , Molecular Structure , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Nitro Compounds/chemistry , Rats , Rats, Wistar , Signal Transduction/drug effects , Spectrometry, Mass, Electrospray Ionization , Spectrophotometry, Infrared , Vasodilation/drug effectsABSTRACT
A duplicated nitrotienyl derivative was obtained as a by-product from the synthesis of a proposed molecular hybrid of a nitrotienyl derivative and isoniazid with an expected dual antimycobacteria mechanism. The structure was shown to be the 5,5'-dinitro-2-(2,3-diaza-4-(2'-tienyl)buta-1,3-dienyl)tiophene by X-ray crystallography. The minimal inhibitory concentration (MIC) determination of this compound proved to be promising against Mycobacterium pathogenic strains such as M. avium and M. kansasii, although it had a high level of mutagenicity, as observed in mutagenic activity tests.
Subject(s)
Antitubercular Agents/chemical synthesis , Antitubercular Agents/pharmacology , Mycobacterium avium/drug effects , Mycobacterium kansasii/drug effects , Nitro Compounds/chemical synthesis , Nitro Compounds/pharmacology , Thiophenes/chemical synthesis , Thiophenes/pharmacology , Antitubercular Agents/chemistry , Crystallography, X-Ray , Microbial Sensitivity Tests , Models, Molecular , Molecular Structure , Nitro Compounds/chemistry , Structure-Activity Relationship , Thiophenes/chemistryABSTRACT
Three new nitrofuryl substituted 1,4-dihydropyridine derivatives were electrochemically tested in the scope of newly found compounds useful as chemotherapeutic alternative to the Chagas' disease. All the compounds were capable to produce nitro radical anions sufficiently stabilized in the time window of the cyclic voltammetric experiment. In order to quantify the stability of the nitro radical anion we have calculated the decay constant, k2. Furthermore, from the voltammetric results, some parameters of biological significance as E7(1) (indicative of in vivo nitro radical anion formation) and KO2 (thermodynamic indicator of oxygen redox cycling) have been calculated. From the comparison of E7(1), KO2 and k2 values between the studied nitrofuryl 1,4-DHP derivatives and well-known current drugs an auspicious activity for one of the studied compounds i.e. FDHP2, can be expected.
Subject(s)
Dihydropyridines/chemistry , Niacin/analogs & derivatives , Nitro Compounds/chemical synthesis , Nitrofurans/chemistry , Quaternary Ammonium Compounds/chemistry , Anions/chemical synthesis , Anions/chemistry , Electrochemistry , Free Radicals/chemical synthesis , Free Radicals/chemistry , Hydrogen-Ion Concentration , Molecular Structure , Niacin/chemistry , Nitro Compounds/chemistryABSTRACT
In the present paper, a direct quenching of radical species by a number of synthesized nitrosoaryl 1,4-dihydropyridines and their parent nitroaryl 1,4-dihydropyridines was determined in aqueous media at pH 7.4. These two series of compounds were compared with the C-4 unsubstituted 1,4-dihydropyridines derivatives and the corresponding C-4 aryl substituted 1,4-dihydropyridines derivatives. Kinetic rate constants were assessed by UV-Vis spectroscopy. Nitrosoaryl derivatives were more reactive than the parent nitroaryl 1,4-dihydropyridines. Our results strongly support the assumption that the reactivity between the synthesized 1,4-dihydropyridines derivatives with alkylperoxyl radicals involves electron transfer reactions, which is documented by the presence of pyridine as final product of reaction and the complete oxidation of the nitroso group to give rise the nitro group in the case of the nitrosoaryl 1,4-dihydropyridines derivatives.
Subject(s)
Dihydropyridines/chemistry , Free Radicals/chemistry , Nitro Compounds/chemistry , Peroxides/chemistry , Sulfonic Acids/chemistry , Benzothiazoles , Cations/chemistry , Chromatography, High Pressure Liquid , Dihydropyridines/chemical synthesis , Gas Chromatography-Mass Spectrometry , Molecular Structure , Nitro Compounds/chemical synthesisABSTRACT
In 6-methyl-N-(4-nitrobenzoyl)-5,6-dihydropyridin-2(1H)-one, C(13)H(12)N(2)O(4), (I), the piperidone ring is in a distorted half-chair conformation. In 8-methoxy-3-methyl-N-(4-nitrobenzoyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline-1,6-dione, C(18)H(20)N(2)O(6), (II), the heterocyclic ring is in a slightly distorted half-boat conformation, while the other six-membered ring is in a distorted chair conformation. Compound (II) presents a strong intramolecular C-H...O hydrogen bond. In both (I) and (II), the molecules interact through C-H...O interactions.
Subject(s)
Excitatory Amino Acid Antagonists/chemistry , Isoquinolines/chemistry , Nitro Compounds/chemistry , Pyridines/chemistry , Quinolines/chemistry , Receptors, AMPA/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Crystallography, X-Ray , Excitatory Amino Acid Antagonists/chemical synthesis , Isoquinolines/chemical synthesis , Molecular Structure , Nitro Compounds/chemical synthesis , Pyridines/chemical synthesis , Quinolines/chemical synthesis , Quinolines/pharmacologyABSTRACT
Abstract-Molluscicidal bioassays and electrochemical studies (measurement of first wave reduction potential, Epcl) were performed on several synthetic nitroaromatics, in relation to possible correlation between biological activity, redox potential and structural effects. Five of them presented a significant molluscicidal activity on Biomphalaria glabrata (LD50 < 20 ppm). The Epc1 values ranged from -0.532 to -0.857 V versus Ag/AgCl (0.1 M) (-0.260 to -0.585 V versus NHE), all of them, in the favorable range for reduction in vivo. Data comparison between Epc1 and molluscicidal activity indicates that the presence of the electroactive nitro group is important for the biological activity. Correlation with redox potential, however, was not evident. Structural effects seem to be the most important parameter. Higher activity is noticeable for phenols, including the para-nitro azo or hydrazo-containing compounds. No activity was observed for compounds having the benzylic substituent in meta position to the nitro group. These results suggest that activity undoubtedly involves more than reduction characteristics and that the possible formation of electrophilic species, after nitro reduction, can play an important role in molluscicidal activity against B. glabrata.
Subject(s)
Antiparasitic Agents/pharmacology , Mollusca/drug effects , Nitro Compounds/pharmacology , Nitrobenzenes/pharmacology , Animals , Antiparasitic Agents/chemical synthesis , Antiparasitic Agents/chemistry , Electrochemistry , Inhibitory Concentration 50 , Nitro Compounds/chemical synthesis , Nitrobenzenes/chemical synthesis , Nitrobenzenes/chemistry , Oxidation-Reduction , Schistosomiasis mansoni/drug therapy , Snails/drug effects , Structure-Activity RelationshipABSTRACT
A series of ten 1-[(5-nitrothenylidene)amino]azoles has been synthesized by the reaction of 5-nitrothiophene-2-carbaldehyde with 1-aminopyrazole, 1-aminoimidazole, 1- and 4- amino-1,2,4-triazoles, 1-aminoindole, 1- and 2-aminoindazoles, 1-aminobenzimidazole and 1- and 2-aminobenzotriazoles. Physical data, spectroscopic characteristics and biological properties of all the derivatives have been examined. The antiprotozoal activity has been tested against Trypanosoma cruzi, comparative to Nifurtimox (Lampit).